Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome

被引:126
作者
Matsumoto, M
Kokame, K
Soejima, K
Miura, M
Hayashi, S
Fujii, Y
Iwai, A
Ito, E
Tsuji, Y
Takeda-Shitaka, M
Iwadate, M
Umeyama, H
Yagi, H
Ishizashi, H
Banno, F
Nakagaki, T
Miyata, T
Fujimura, Y
机构
[1] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 6348522, Japan
[2] Nara Med Univ, Dept Hlth Sci, Kashihara, Nara 6348522, Japan
[3] Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 565, Japan
[4] ChemoSeroTherapeut Res Inst, Res Dept 1, Kumamoto, Japan
[5] Toyama City Hosp, Dept Pediat, Toyama, Japan
[6] Fukui Red Cross Hosp, Dept Pediat, Fukui, Japan
[7] Yamaguchi Univ, Sch Med, Dept Blood Transfus Med, Ube, Yamaguchi 755, Japan
[8] Kagawa Childrens Hosp, Dept Pediat, Zentsuji, Japan
[9] Hirosaki Univ, Sch Med, Dept Pediat, Hirosaki, Aomori 036, Japan
[10] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan
[11] Kitasato Univ, Sch Pharmaceut Sci, Tokyo, Japan
关键词
D O I
10.1182/blood-2003-06-1796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report here 7 new mutations in the ADAMTS13 gene responsible for Upshaw-Schulman syndrome (USS), a catastrophic phenotype of congenital thrombotic thrombocytopenic purpura, by analyzing 5 Japanese families. There were 3 mutations that occurred at exon-intron boundaries: 414+1G >A at intron 4, 686+1G >A at intron 6, and 1244+2T>G at intron 10 (numbered from the A of the initiation Met codon), and we confirmed that 2 of these mutations produced aberrantly spliced messenger RNAs (mRNAs). The remainIng 4 mutations were missense mutations: R193W, 1673F, C908Y, and R1123C. In expression experiments using HeLa cells, all mutants showed no or a marginal secretion of ADAMTS13. Taken together with the findings in our recent report we determined the responsible mutations in a total of 7 Japanese patients with USS with a uniform clinical picture of severe neonatal hyperbillrubinemia, and in their family members, based on ADAMTS13 gene analysis. Of these patients, 2 were homozygotes and 5 were compound heterozygotes. The parents of one homozygote were related (cousins), while those of the other were not. Molecular models of the metalloprotease, fifth domain of thrombospondin 1 (Tsp1-5), and Tsp1-8 domains of ADAMTS13 suggest that the missense mutations could cause structural defects in the mutants. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:1305 / 1310
页数:6
相关论文
共 35 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]  
[Anonymous], CHEM BIOINFO
[3]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[4]  
Bell WR, 1997, SEMIN HEMATOL, V34, P134
[5]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[6]   2 angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode [J].
Cirilli, M ;
Gallina, C ;
Gavuzzo, E ;
Giordano, C ;
GomisRuth, FX ;
Gorini, B ;
Kress, LF ;
Mazza, F ;
Paradisi, MP ;
Pochetti, G ;
Politi, V .
FEBS LETTERS, 1997, 418 (03) :319-322
[7]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[8]   Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome [J].
Fujimura, Y ;
Matsumoto, M ;
Yagi, H ;
Yoshioka, A ;
Matsui, T ;
Titani, K .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) :25-34
[9]   Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Wassmer, M ;
Sandoz, P ;
Lammle, B .
BLOOD, 1997, 89 (09) :3097-3103
[10]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584